Abstract
Paramagnetic lanthanide ions when bound to proteins offer great potential for structural investigations that utilize solution nuclear magnetic resonance spectroscopy, magnetic resonance imaging, or optical microscopy. However, many proteins do not have native metal ion binding sites and engineering a chimeric protein to bind an ion while retaining affinity for a protein of interest represents a significant challenge. Here we report the characterization of an immunoglobulin G-binding protein redesigned to include a lanthanide binding motif in place of a loop between two helices (Z-L2LBT). It was shown to bind Tb3+ with 130 nM affinity. Ions such as Dy3+, Yb3+, and Ce3+ produce paramagnetic effects on NMR spectra and the utility of these effects is illustrated by their use in determining a structural model of the metal-complexed Z-L2LBT protein and a preliminary characterization of the dynamic distribution of IgG Fc glycan positions. Furthermore, this designed protein is demonstrated to be a novel IgG-binding reagent for magnetic resonance imaging (Z-L2LBT:Gd3+ complex) and luminescence microscopy (Z-L2LBT: Tb3+ complex).
Keywords: lanthanide binding, imaging reagents, protein NMR, immunoglobulin label, protein design
Introduction
The development of techniques to harness the unique properties of lanthanide series metals can have substantial impact on the field of structural and molecular biology. These properties have been exploited in the past using techniques as diverse as nuclear magnetic resonance (NMR) spectroscopy,1 electron paramagnetic resonance (EPR) spectroscopy,2,3 magnetic resonance imaging (MRI)4, X-ray crystallography,5 and luminescence imaging.6,7 In NMR the relaxation enhancing and chemical shift perturbing properties of paramagnetic lanthanide ions give rise to ion-nucleus distance measurements in the 10 to 50 Å range. In EPR, more specifically DEER applications, this range can approach 100 Å.8 In MRI these same paramagnetic properties give rise to image contrast enhancement, and, in microscopy applications, long-lived Tb3+ and Eu3+ luminescence (>2 ms)7,9 offers potentially unique advantages in background suppression and multiple photon excitation.6 The luminescent properties are also useful in the determination of ion dissociation constants or distance-dependent energy transfer to a nearby fluorophore.9 To fully capitalize on these properties, the capacity to bind a lanthanide ion into a molecule of interest must be developed. Here we present the redesign of a small protein domain known to bind the immunoglobulin G (IgG) fragment crystallizable (Fc) to include a lanthanide binding motif. The use of this particular domain amplifies the potential impact because of the widespread use of IgG-based antibodies in cell biology and biomedical research.
The actual choice of IgG, a small binding protein, and a lanthanide binding motif were strongly influenced by our interest in carbohydrate–protein interactions and how covalently-attached glycans in glycoproteins impact protein function.10,11 IgG Fc and its attached glycans are of particular interest as these glycans modulate the interaction of Fc with the various Fcγ receptors.12 Furthermore, alteration in glycan composition can shift the normally proinflammatory Fc into a potent anti-inflammatory mediator.13,14 An elucidation of the structural and dynamic characteristics of the glycans by methods such as solution NMR would do much to provide an understanding of these effects. IgG Fc is a dimer that contains two Asn-linked glycans, but structural studies of these glycans are limited by dynamic motions that prevent observable glycan-polypeptide distance measurements in the form of NOE crosspeaks in isotope edited NMR experiments.11 Also, preparing the properly glycosylated and isotope labeled Fc protein is challenging, due to the lack of N-glycosylation machinery in Escherichia coli and inappropriate glycosylation found when using many eukaryotic expression techniques.15 Even if the protein amino acids could not be isotopically labeled, characterization of the IgG glycans would be facilitated by attachment of a lanthanide ion to the Fc polypeptide, as would the structural elucidation of molecules in complex with Fc.
Hence, we have resorted to the incorporation of a lanthanide binding capacity into the Z-domain of the Fc-binding protein, Protein A. This new chimeric protein can be expressed at will and used with even native, non isotope enriched, isolations of IgG Fc fragments. The paramagnetic properties of lanthanide ions can then provide valuable long-range orientation and distance information which can supplant measurements of short-range nuclear dipole-dipole interactions (NOEs, <5–6 Å),16,17 the traditional foundation of structure determination by solution-state NMR spectroscopy.18
Many strategies to label molecules of interest with lanthanide binding motifs have been presented previously, including: covalent modification with a metal chelate,5,17 integration of an unnatural amino acid carrying a chelate moiety,19 and the incorporation of an internal lanthanide binding polypeptide sequence into the protein expression construct.20–22 Many of these strategies provide limited benefits for structure-based investigations due to the conformationally labile nature of the lanthanide-binding motifs. Steric restriction has been achieved by using rigid chelates,23 chelates with multiple protein attachment sites,24 and integration of a lanthanide binding peptide into the middle, as opposed to the terminus of a protein sequence.25 In general we prefer the lanthanide binding peptide approach for its convenience of production by expression in a bacterial host. With our choice of a small protein with affinity for IgG Fc this is entirely feasible. We also prefer the introduction in midsequence since our long-term objectives are to use the chimeric protein in structural characterization, and restricting internal mobility is important.
The lanthanide binding peptide we chose is a short ∼20 amino acid sequence that can be added to the termini of protein sequences or in place of loop structures already in the protein to be modified.21,24,25 Substitution for native loop structures in a manner that preserves both lanthanide binding sequences and affinity for a target protein, IgG Fc in our case, is not always straight forward. We have therefore used generous linkers between the peptide and protein at some sacrifice to rigidity for this initial application. In this way, we have succeeded in producing a modified Z-domain with a lanthanide binding motif (or tag, LBT) inserted between helices two and three of the Z-domain three helix bundle. The construct has been demonstrated to preserve binding properties for both lanthanides and IgG Fc, and we have illustrated the utility of paramagnetic perturbations by determining the position of the lanthanide in a model of the modified Z-domain, as well as assessing the distribution of glycan conformers in IgG Fc. In addition, we have made preliminary applications to demonstrate the potential of this construct as a reagent to enhance contrast for MRI and confocal luminescence microscopy.
Results
Design of the lanthanide binding Z-domain
The Z-domain, a designed protein based on the B domain of the Staphylococcus aureus Protein A,26 was chosen as a target for insertion of a lanthanide binding motif because of its high affinity for IgG Fc,27 relative structural simplicity,28,29 and thermal stability.30 In an effort to reduce the conformational heterogeneity experienced by a motif attached at only the N or C terminus (data not shown), the motif was inserted in place of the loop between helices 2 and 3. The sequence of the lanthanide binding motif (Fig. 1) is based upon that of Nitz et al.20 as modified by Su et al.22 to remove the two C-terminal residues (Leu and Ala) and replace the Trp with Ala. The entire construct, which also contains a 6xHis tag at the N-terminus, is shown in Figure 1. This design, Z-L2LBT, was expressed at a high level in E. coli cells (>20 mg/mL) and was of high purity (>95%) after a single immobilized Ni2+ affinity chromatography step (Supporting Information Fig. S1). Binding of Tb3+ to purified Z-L2LBT resulted in the appearance of a peak at ∼280 nm in the luminescence absorbency profile, suggesting Tb3+ sensitization occurs through proximal Tyr sidechains in the protein [Fig. 1(B)]. A titration of Z-L2LBT with Tb3+ revealed a dissociation constant of 130 ± 30 nM [Fig. 1(C)], a value consistent with expectations based upon a similar polypeptide sequence.20 Furthermore, Z-L2LBT was shown to bind lanthanide ions and IgG Fc simultaneously using NMR titrations at 25°C and 50°C as well as SDS-PAGE-detected binding to an IgG2a-Sepharose resin in the presence of Tb3+ at 25°C (data not shown).
Figure 1.

The chimeric Z-L2LBT protein (A) is built upon a IgG-binding Z-domain scaffold and contains a lanthanide binding motif in place of the loop between helices 2 and 3. (B) Luminescence intensity changes with the Tb3+coordination state. The shift of the Tb3+:Z-L2LBT profile to the UV region likely reflects sensitization of the Tb3+ ion through Tyr residues in the protein. A sharp instrument artifact observed at ∼272 nm in all samples including a water blank was removed from these plots. (C) Luminescence intensity saturates at higher concentrations of Tb3+ when titrated into a 0.85 μM solution of Z-L2LBT. These data are fit with Eq. (1).
Determining the location of the lanthanide ion using paramagnetic effects
The designed Z-L2LBT protein was highly soluble and a heteronuclear single quantum coherence (HSQC) spectrum of a 15N-labeled version showed ∼80 amide crosspeaks of similar intensity. Roughly 30 crosspeaks disappeared and reappeared in a different location during a titration of Z-L2LBT with diamagnetic Lu3+ ions. A spectrum for the Lu3+-saturated Z-L2LBT is shown in Figure 2. The dissociation of the Lu3+:Z-L2LBT complex was slow on the NMR timescale (data not shown) and agreed with expectations based upon the relatively small Tb3+ dissociation constant reported above. The crosspeaks were assigned using a suite of standard triple resonance experiments.
Figure 2.

15N heteronuclear single quantum coherence spectrum of Z-L2LBT bound to a diamagnetic Lu3+ ion (black spectrum) or a paramagnetic Dy3+ ion (grey spectrum). The PCS and PRE effects of the Dy3+ ion appear as frequency shifts (diagonal lines), broadened lines and reduced intensity (inset), respectively, of 1H-15N cross peaks. The numbers indicate residue numbers in the amino acid sequence. For protein preparation and purity see also Supporting Information Figure S1.
An 15N-HSQC spectrum of a complex between Z:L2LBT and a paramagnetic Dy3+ ion showed clear paramagnetic effects including resonance frequency perturbations (pseudocontact shifts (PCS)), reduced crosspeak intensities, and increased 1H linewidths (paramagnetic relaxation enhancement (PRE)) as shown in Figure 2. The characteristic shift of 15N-1H crosspeaks along a diagonal line, resulting from a near equal perturbation of 15N and 1H resonance positions on a parts-per-million (ppm) scale, provides a useful means of correlating peaks observed in a paramagnetic complex with those already assigned for the diamagnetic (Lu3+) complex. The mere presence of PCSs is suggestive of reduced LBT dynamic freedom that was not observed when using a Z-domain modified with a C-terminal LBT (data not shown). The magnitudes of the induced shifts were determined for Z-L2LBT complexed with Ce3+, Yb3+, and Dy3+ ions, and 1H PRE effects were determined from 1H R2 relaxation rates. In total, 68 PCSs and 46 PREs were measured (see Table I and Supporting Information).
Table I.
Summary of Experimental NMR Constraints and Structural Statistics
| Dihedral-angle constraints | 114 | |
| Residual dipolar coupling constraints | ||
| H-N | 54 | |
| N-C(O) | 34 | |
| Paramagnetic relaxation enhancement constraints | # | R2a |
| Yb3+ | 23 | 0.70 |
| Dy3+ | 23 | 0.71 |
| Pseudocontact shift constraints | # | R2a |
| Ce3+ | 11 | 0.61 |
| Yb3+ | 28 | 0.46 |
| Dy3+ | 29 | 0.86 |
| Total number of restricting constraints | 313 | |
| Rmsd | ||
| Rmsd of backbone atoms (19–87) | 0.4 Å | |
| Bond length | 0.04 Å | |
| Bond angle | 2.2° | |
| Ramachandran analysis | ||
| Most favored region | 88.4% | |
| Allowed region | 11.6% | |
| Generously allowed | 0.0% | |
| Disallowed | 0.0% | |
| PSVS Z-scores31 | ||
| Verify 3D32 | −2.4 | |
| Prosall33 | 1.1 | |
| Procheck (phi-psi)34 | −0.6 | |
| MolProbity35 | −3.8 | |
Correlation between observed values and values back-calculated from the models.
Structures of the independent Z-domain and the LBT have been determined previously by NMR (pdb-1q2n29) and X-ray crystallography (pdb-1tjb36), respectively, and assuming induced structural changes upon substituting the LBT for a Z-domain loop were minimal, it is appropriate to use these in devising a model for the designed Z-L2LBT construct. To validate this assumption, residual dipolar coupling (RDC) data were collected on a Lu3+ bound version of the construct; these are also reported in Table I. RDCs provide high-resolution orientation information on residue-specific 1H-15N bond vectors. Retention of previously determined structures can be assessed based upon a Q value that compares experimental RDCs and RDCs back-calculated from a proposed structure.37 Q values <0.4 are suggestive of a high degree of structural similarity between the actual structure and a proposed model. Q values of Z-L2LBT 15N-1H and 15N-13C(O) RDCs measured in PEG bicelles are 0.201 and 0.369, respectively, when compared with the X-ray crystallography structure of the unmodified Z-domain and 0.338 and 0.363, respectively, when compared with the X-ray crystallography structure of the LBT. In addition, the resonance frequencies for residues in the three helices were quite similar to those previously determined for the isolated Z-domain,29 and these were used to confirm backbone torsional constraints. The RDC Q values and differences between the resonance frequencies are sufficiently low to suggest a high degree of similarity between the previously determined structures of the individual domains and those domains in Z-L2LBT. Thus, the structure determination was restricted to finding the relative orientation and position of the LBT and Z portions.
The approximate location of the lanthanide ion relative to the three helix bundle was calculated initially using PCS and PRE constraints (Table I) in a grid search. The LBT and linking loop segments were then docked to satisfy this position without violating covalent geometry and van der Waals contact restrictions. Next, the structure and fine position of the ion were refined using a simulated annealing routine in XPLOR-NIH.38 Agreement between the experimental paramagnetic restraints and values calculated using the final set of structures is shown in Supporting Information Figure S2. In the lowest-energy structures, shown in Figure 3, the LBT is oriented perpendicular to the axis of the three helices in the direction of the surface cleft formed between helices 1 and 2.
Figure 3.

Models of Z-L2LBT calculated with restraints from paramagnetic ion perturbations. Overlay of the backbone is shown for the ensemble of 10 models (A, and as rotated 90°, B). A ribbon diagram of the lowest energy model shows the structural elements (C and as rotated 90°, D). (E) A model of the (Z-L2LBT:Ln3+)2–Fc complex. This figure was generated using PyMol.
Calculation of PRE values was based on an assumed Curie mechanism in which only auto correlation terms from nuclear spin—dipolar shielding anisotropy (DSA) interactions were considered. It has been reported that chemical shift anisotropy (CSA)—DSA cross correlation can contribute to observed paramagnetic lanthanide PRE rates, and unlike other nuclear contributions, these effects cannot be canceled by subtracting the relaxation rates for the protein bound to a diamagnetic ion.39 This becomes an issue particularly at large metal—nucleus internuclear vector correlation times (>20 ns) or for small PRE values (<15–20 s−1). These effects were neglected here due to the low Z-L2LBT correlation time (∼6 ns), and relatively large PREs used in our calculations (see Supporting Information). Maximum errors in the 13 Å distance computed from a PRE of 50 s−1 for an idealized Dy3+ complex without internal motions and with a 5 ns correlation time at 14T are approximately −1 and +2 Å at the limiting angles of relative CSA and DSA tensor orientations.38
Z-L2LBT dynamics
Independent analysis of RDCs for the LBT and Z-domain suggest Z-L2LBT exhibits substantial internal motional dynamics. Fitting RDCs for the two moieties independently produced different principle alignment parameters indicating motion of the LBT relative to the Z-domain. Thus, RDC data were not used to refine the final Z-L2LBT structure. The presence of dynamic differences in the Z and LBT portions was further probed by measuring R1 and R2 relaxation rates for 15N nuclei as shown in Figure 4. Resonances from the LBT are characterized by slightly greater R1 rates and a mixture of R2 rates that are larger and smaller than those of the helices. This result is consistent with an LBT that experiences dynamic motions that are in general faster than the global Lu3+:Z-L2LBT tumbling correlation time of ∼6 ns, with a few residues experiencing R2 relaxation enhancement by conformational exchange on a slower timescale. The number of measures, particularly for the LBT, are not adequate to provide an accurate amplitude of interdomain motion, however, principal alignment parameters from RDC data (Da = −5.74 × 10−4, 2.17 × 10−4 and R = 0.60, 0.19 for Z-domain helices and the LBT, respectively) would suggest a motional amplitude of approximately 40° if a simple diffusion-on-a-cone model pertained. PCSs, due in part to the r−3 distance-dependency, and PREs, are less sensitive to interdomain conformational heterogeneity than RDCs, particularly those for sites at longer distances. The good, but imperfect, fits of experimental and back-calculated PRE and PCS data (Supporting Information Fig. S2) are explained by a combination of LBT mobility and cross-correlation effects. However, the fits are more than adequate to support the use of paramagnetic-derived restraints, particularly PCSs, in building structural models such as the ones presented here.
Figure 4.

The 15N relaxation rates R1 (A) and R2 (B) of Z-L2LBT show the Z domain and LBT regions have different dynamic characteristics.
Assessment of Fc N-glycan conformational distribution
The spatial orientations of the N-glycan termini relative to the Fc polypeptide were probed using the distance-dependent line-broadening properties of lanthanide ions. A spectrum of Fc bound by two Z-L2LBT molecules, each coordinating a Gd3+ ion, showed considerable broadening of 13C-HSQC crosspeaks from the N-glycan's terminal galactose (Gal) residue when compared to a spectrum without a lanthanide ion (Fig. 5). A simple analysis indicated the degree of broadening (∼60 Hz) due to the lanthanide is inconsistent with that expected (1–3 Hz) based upon internuclear Gal–lanthanide distances (30–35 Å) in models based on the placement of Z-domain helices and glycans in crystallography studies40 [Fig. 3(E)]. This supports the suggestion that in solution the glycan termini deviate from the position observed in solid-state structures of the Fc determined by X-ray crystallography11 and make excursions that bring the Gal residues closer to the lanthanide ion. More complete NMR studies combined with long molecular dynamics simulations may allow a description of the conformational ensemble of exposed glycan structures and the locations of the Gal residues.
Figure 5.

Fc N-glycan resonances are perturbed by lanthanides bound to Z-L2LBT. (A) A portion of the 13C-HSQC spectrum at 14.1 T shows Gal resonances of Fc with a Gal-terminated N-glycan. (B) A slice through the C2-H2 crosspeak in (A) shows the H2 lineshape. (C) A portion of the 13C HSQC spectrum showing Gal resonances of (Gd3+:Z-L2LBT)2:(13CU-Gal Fc) complex; (D) a slice through the C2-H2 crosspeak in (C). The intense peak at 3.5 ppm in (C) is folded from another part of the spectrum and does not represent a new peak in the viewing window.
Magnetic resonance imaging of IgG:Z-L2LBT complexes
Z-L2LBT has a significant potential as an imaging probe as well as an NMR probe. IgG antibodies prepared against specific antigens recognize target epitopes with incredible specificity through antigen-binding domains, and Z-L2LBT bound to the Fc of these antibodies is capable of specifically illuminating a tissue or other structures of interest by concentrating Gd3+ ions for magnetic resonance imaging. The invariant nature of the Fc fragment in these antibodies allows Z-L2LBT to bind a large variety of IgG1 and IgG2 monoclonal antibodies.27
As a surrogate for a tissue sample, a 3 mm phantom was created by sandwiching a layer of IgG2a-conjugated Sepharose® beads between two layers of unconjugated beads in an NMR tube as shown in Figure 6. The paramagnetic properties of lanthanide ions, particularly Gd3+, enhance the contrast in magnetic resonance images.7 The IgG2a beads concentrated Gd3+:Z-L2LBT from the bulk solution of dilute Gd3+:Z-L2LBT and were easily detected in a 1D 1H image of the phantom (Fig. 6). While this illustration employed just a 1D projection of an image, the possibilities of extension to three-dimensional imaging are clear.
Figure 6.

A gradient profile at 14.1 T of IgG2a-coated sepharose® beads sandwiched between two layers of unconjugated Sepharose® beads. This solution contains Gd3+:Z-L2LBT. Reduced 1H T1 times resulting from the concentration of Gd3+ by the IgG2a-coated beads give rise to greater intensity in the gradient profile which corresponds to the location of IgG2a-coated beads in a 3 mm NMR tube. A photograph of the phantom is shown.
Luminescence microscopy
The presence of Z-L2LBT:IgG may also be detected with luminescence microscopy when it carries a Tb3+ ion. IgG2a on the surface of a Sepharose® bead was detected by observing Tb3+ luminescence with a standard laser-scanning confocal microscope as shown in Figure 7. In the absence of a laser suitable for excitation at the 1-photon absorption band, a two-photon pathway was employed with irradiation at 560 nm. This reduces efficiency, but points to utility in combination with the longer wavelength irradiation typically used in tissue samples. The full advantage of background suppression using time-resolved methods was not explored.
Figure 7.

Z-L2LBT bound to Tb3+ is a reagent for luminescence microscopy. Images of control Sepharose® beads (A) or mouse IgG2a-coated Sepharose® beads were obtained in the presence of Tb3+:Z-L2LBT. The beads are 45 to 165 μm Sepharose® 4B resin (Sigma). The average signal above background for ∼50 beads from each trial is shown ± standard error (C).
Discussion
Z-L2LBT, even as currently designed, is well suited for many types of structural studies employing Fc-containing and Fc-binding molecules. The internal mobility of the current lanthanide-binding motif is only a minor inconvenience and can likely be ignored in studies in which constraints are long range. However, an improved design with reduced LBT motion would be useful both in terms of simplifying analysis and generating an alternative lanthanide ion position. We anticipate that the paramagnetic properties of improved lanthanide ion coordinating motifs will be crucial to defining the ensemble of dynamic glycan structures and providing information as to the location of the glycan termini in the context of the Fc glycoprotein.11 Furthermore, effects of CSA × DSA cross-correlation on PRE measurements are also expected to be negligible for application to glycans. The CSA of aliphatic carbohydrate nuclei are expected to be much smaller (1H ∼1–2 ppm; 13C ∼20–40 ppm)41,42 than the protein amides (1H ∼10 ppm; 15N ∼140–170 ppm),43 and thus would minimally impact PRE measurements. These data will be important to defining the mechanism by which the Fc N-glycan modulates immune system activation.44
Applying Z-L2LBT as an in vivo MRI contrast reagent will likely require other types of optimization, including redesign to permit greater water access to the ion. Gd3+-based reagents also face scrutiny due to toxicity in certain patients with reduced renal function that causes slow clearance and accumulation of released ion.45 This limitation would be mitigated by optimizing the LBT sequence for enhanced Gd3+ affinity, which could be accomplished either by directed mutagenesis based on a high-resolution crystal structure of Z-L2LBT or random mutagenesis of the ion binding motif. Similar optimization of the Z-domain could in principle introduce specificity for immunoglobulin subtypes, or even introduce affinities for unrelated molecules. It is noteworthy that the Z-domain has been the structural basis for designed affinity reagents such as affibodies.46,47
Using Z-L2LBT as an optical imaging probe will likely benefit from similar modifications; however, LBT modifications and instrumentation for optimal detection of the probe will also be needed to enhance sensitivity. This version of the LBT removed a Trp residue that presumably would increase the excitation efficiency. The microscopy described here is suboptimal due to the available excitation wavelength (559 nm); the optimal excitation wavelength for this complex would be ∼280 nm [Fig. 1(B)]. The long wavelength excitation achieved here may reflect two-photon excitation6 of Tb3+ which is conventionally achieved with high-intensity pulsed laser excitation of fluorophores with longer wavelength absorption profiles (one-photon 500–600 nm; two-photon 1000–1200 nm).48 Despite the limitation, clear enhancement of the Tb3+ signal could be attributed to the IgG2a bead surface and future signal enhancement will come by exciting at a shorter wavelength (280 nm) or using a pulsed, high-intensity laser tunable to 560 nm. Pulsed laser operation with delayed detection of luminescence would be of considerable value in suppressing background fluorescence in biological samples, and may even allow access to time course measurements on the ms timescale.
Conclusion
The design of Z-L2LBT combined high affinity for IgG Fc and lanthanide ions into a single polypeptide that can be efficiently expressed in E. coli cells. This chimera opens new avenues of structural and molecular biology research that utilize lanthanide properties, including paramagnetic relaxation enhancement, pseudocontact shifts of resonance frequencies and luminescence. Applications are broadened by the occurrence of Fc domains in the wide variety of monoclonal antibodies available for biomedical research.
Materials and Methods
Materials
All materials, unless otherwise noted, were obtained from Sigma-Aldrich. Stable isotope-enriched materials were purchased from Cambridge Isotopes. Human serum IgG Fc was from Athens Research & Technology. IgG Fc with 13C-Gal terminated N-glycans was prepared as previously described.11
Cloning, expression, and purification of Z-L2LBT
Constructs of the Z-domain were synthesized (Genscript) that contained the LBT at the C-terminus or between helices 2 and 3 (Z-L2LBT). Pseudocontact shifts were not observed when using the C-terminal design and this construct was not pursued further. These constructs were also designed to have an N-terminal 6-residue poly His tag.
The Z-L2LBT coding region was cloned into a pET29 expression vector (Novagen) and transformed into E. coli BL21(DE3) cells for expression. Protein was expressed in M9 minimal medium that included either 15N-enriched ammonium chloride or a combination of 15N-enriched ammonium chloride, 13C-enriched glucose and >95% 2H2O. These cultures were allowed to grow to an OD600 = 0.5 at which point expression was induced with 0.5 mM IPTG. The cells were then incubated at 18°C with shaking for 15 to 18 h. After harvesting, cells were lysed using the French press method. Protein was purified using a Ni2+-NTA resin according to the instructions of the manufacturer (Qiagen). Protein was treated with a 10× molar concentration of EDTA and dialyzed against a buffer containing 25 mM MOPS, 100 mM KCl, pH 7.2 to remove imidazole and EDTA. All steps of expression and purification were monitored by SDS PAGE (see Supporting Information Fig. S1).
Determination of the Tb3+ dissociation constant
Titration of 1 μM Z-L2LBT with Tb3+ was monitored using a Shimadzu RF-5301PC spectrofluorophotometer by exciting at 280 nm and reading the intensity change at 490 and 545 nm. The intensity data were fitted to an equation describing a binding isotherm:
where FB is the fraction bound, [P] is the protein concentration, [Tb3+] is the terbium ion concentration, and KD is the dissociation constant.
NMR spectroscopy
NMR spectroscopy was performed on Varian instruments with a VNMRS (21.1 T and 14.1 T) or INOVA (a different 14.1 T) console and equipped with a 3 mm (14.1 T) or 5 mm (21.1 T and 14.1 T) cryogenically cooled probe. NMR samples were between 100 and 900 μM and in a buffer containing 25 mM MOPS, 100 mM KCl, and 10% 2H2O, pH 7.2. Two-dimensional 15N-HSQC experiments for assessing paramagnetic resonance frequency shifts and measuring 15N relaxation rates were from the Varian BioPack distribution. Relaxation rates (1H) were measured at 21.1 T by placing a simple Carr-Purcell R2 relaxation element49 with a single protein refocusing pulse at the beginning of a standard 15N-HSQC pulse sequence. The effect of field induced RDCs and subsequent modulation of three-bond proton couplings were neglected due to the weak observed alignment of a Dy3+-bound form. Three-dimensional HNCO, HNCOCA, HNCACB, and HNCOCACB backbone assignment experiments were collected in the presence of a 1.1 molar excess of Lu3+. Spectra were processed using NMRPipe.50 Backbone resonances were assigned using the tools in the NMRViewJ software package.51 Residues 1–12 were not observed in these experiments, but 98.6% (HN), 96.1% (N), 100% (Cα), 100% (Cβ), and 94.7% (C) of the resonances from residues 13–88 were assigned and are deposited in the BMRB (accession 18,126). Crosspeaks from 15N-HSQC spectra collected in the presence of Dy3+, Yb3+, or Ce3+ were assigned by inspection using the assigned shifts from the Lu3+ complex according to the method of Otting.1
Lu3+:Z-L2LBT was partially aligned in 4.2% (v/v) C12E5 alkyl-polyethylene glycol (PEG) bicelle using previously published protocols.52 Specifically, 16% (v/v) C12E5 PEG stock was prepared by mixing 50 μL of PEG, 50 μL of 2H2O, 200 μL of protein buffer (25 mM MOPS, 100 mM KCl, 10% 2H2O, pH 7.2), and 16 μL of hexanol. The alignment medium was then prepared by mixing 55 μL of 16% PEG stock with 145 μL of protein solution and 20 μL of D2O to reach 4.2%. RDCs of 1H-15N amide pairs were measured using a J-modulated experiment.53 N-C(O) residual dipolar couplings were measured according to Liu and Prestegard.54
In preparation of a phantom for magnetic resonance imaging, Sepharose® 4B (Sigma #4B-200) beads and Sepharose® 4B [anti-(human placental) alkaline-phosphatase specific monoclonal mouse IgG2a]-conjugated beads (∼12 μL; Sigma #A2080) were washed separately and thoroughly in a buffer containing 25 mM MOPS, 100 mM KCl, pH 7.2. The beads placed in 3 mm tube were resuspended in a buffer containing 15 μM Z-L2LBT, 17 μM Gd3+, 25 mM MOPS, 100 mM KCl, pH 7.2. A T1-weighted, one-dimensional 1H magnetic resonance image was obtained using the “gmapz” gradient profile experiment supplied with Varian instruments.55 The recycling delay was set to 0.5 s with a gradient strength and duration of 9 G/cm and 3.2 ms, respectively.
Structure calculation
Backbone dihedral angles were predicted using TALOS based on the assigned chemical shifts of the HN, CA, CB, CO, and N nuclei.56 Starting Da and R values for the partially aligning PEG medium were calculated from principle order parameters determined in PALES.57 Starting Da and R values as well as x, y, z coordinates for the ion were calculated using NUMBAT.58 Enhanced relaxation due to the presence of a paramagnetic metal ion (PRE) was determined by subtracting amide 1H R2 values measured with Lu3+:L2LBT from R2 values measured with Z-L2LBT in a complex with each of the paramagnetic ions. An initial PRE scaling factor was found by assuming a τc value and optimizing the fit during the structure calculation. The structural refinement was performed using PRE rate,59 dihedral angle, and RDC orientation constraint (for PCS refinement) modules available in XPLOR-NIH.38 The structure of residues 19 to 31, 37 to 48, and 73 to 86 were fixed based upon their location in the pdb structure (1q2n); likewise the structure of the lanthanide and coordinating residues 54 to 64 was held constant based upon (pdb)1tjb structure. The top 10 structures with the lowest total energy of the 50 calculated structures were selected for final structure deposition. The results of these refinements are summarized in Table I. The quality of the structural models was verified using the Protein Structure Validation Suite (PSVS) software (available at: http://psvs.nesg.org).31 Structural models of the Z-L2LBT were deposited into the PDB (2LR2). Models of the Z-L2LBT–IgG Fc complex were obtained by fitting the structure of Z-L2LBT to a crystal structure of a complex between IgG Fc and the first two helices of the Z-domain (1L6X). The observed mobility of the LBT likely permits close contact of the Z-domain to the Fc without greatly perturbing affinity.
Luminescence microscopy
Sepharose® 4B (∼10 μL) beads and IgG2a-sepharose® 4B beads (∼10 μL) were washed separately and thoroughly in a buffer containing 25 mM MOPS, 100 mM KCl, pH 7.2. Beads are between 45 and 165 μm in diameter. Beads were then resuspended in 40 μL of a solution containing ∼300 μM Z-L2LBT, 330 μM Tb3+, 25 mM MOPS, 100 mM KCl, pH 7.2, and placed on a slide. Bead fields were imaged with a 40× (N.A.1.3) oil-immersion objective on an Olympus FV-1000 laser scanning confocal microscope. Multiple images were acquired at 0.5 μM intervals through the z-plane. Fluorescence was excited with a 559 nM laser and emission spectra detected with a 575 to 620 nM filter. Images of control and experimental samples were processed identically using ImageJ60 and pseudocolored with Adobe Photoshop. Images represent maximum intensity projections.
Acknowledgments
The authors thank Dr. Hsiau-Wei Lee for assistance in preparing the partially aligned sample. The content of this work is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
Glossary
Abbreviations
- CSA
chemical shift anisotropy
- DSA
dipolar shielding anisotropy
- EPR
electron paramagnetic resonance
- Fc
fragment crystallizable
- Gal
galactose
- HSQC
heteronuclear single quantum coherence
- IgG
immunoglobulin G
- LBT
lanthanide binding tag
- MRI
magnetic resonance imaging
- NMR
nuclear magnetic resonance
- PCS
pseudocontact shift
- PRE
paramagnetic relaxation enhancement
- RDC
residual dipolar coupling
Supplementary material
Additional Supporting Information may be found in the online version of this article.
References
- 1.Otting G. Prospects for lanthanides in structural biology by NMR. J Biomol NMR. 2008;42:1–9. doi: 10.1007/s10858-008-9256-0. [DOI] [PubMed] [Google Scholar]
- 2.Gordon-Grossman M, Kaminker I, Gofman Y, Shai Y, Goldfarb D. W-Band pulse EPR distance measurements in peptides using Gd(3+)-dipicolinic acid derivatives as spin labels. Phys Chem Chem Phys. 2011;13:10771–10780. doi: 10.1039/c1cp00011j. [DOI] [PubMed] [Google Scholar]
- 3.Yagi H, Banerjee D, Graham B, Huber T, Goldfarb D, Otting G. Gadolinium tagging for high-precision measurements of 6 nm distances in protein assemblies by EPR. J Am Chem Soc. 2011;133:10418–10421. doi: 10.1021/ja204415w. [DOI] [PubMed] [Google Scholar]
- 4.Laurent S, Vander Elst L, Muller RN. Lanthanide complexes for magnetic resonance and optical molecular imaging. Q J Nucl Med Mol Imaging. 2009;53:586–603. [PubMed] [Google Scholar]
- 5.Silvaggi NR, Martin LJ, Schwalbe H, Imperiali B, Allen KN. Double-lanthanide-binding tags for macromolecular crystallographic structure determination. J Am Chem Soc. 2007;129:7114–7120. doi: 10.1021/ja070481n. [DOI] [PubMed] [Google Scholar]
- 6.Law GL, Wong KL, Man CW, Wong WT, Tsao SW, Lam MH, Lam PK. Emissive terbium probe for multiphoton in vitro cell imaging. J Am Chem Soc. 2008;130:3714–3715. doi: 10.1021/ja710418d. [DOI] [PubMed] [Google Scholar]
- 7.Hanaoka K. Development of responsive lanthanide-based magnetic resonance imaging and luminescent probes for biological applications. Chem Pharm Bull (Tokyo) 2010;58:1283–1294. doi: 10.1248/cpb.58.1283. [DOI] [PubMed] [Google Scholar]
- 8.Song Y, Meade TJ, Astashkin AV, Klein EL, Enemark JH, Raitsimring A. Pulsed dipolar spectroscopy distance measurements in biomacromolecules labeled with Gd(III) markers. J Magn Reson. 2011;210:59–68. doi: 10.1016/j.jmr.2011.02.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Selvin PR, Hearst JE. Luminescence energy transfer using a terbium chelate: improvements on fluorescence energy transfer. Proc Natl Acad Sci USA. 1994;91:10024–10028. doi: 10.1073/pnas.91.21.10024. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Barb AW, Brady EK, Prestegard JH. Branch-specific sialylation of IgG-Fc glycans by ST6Gal-I. Biochemistry. 2009;48:9705–9707. doi: 10.1021/bi901430h. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Barb AW, Prestegard JH. NMR analysis demonstrates immunoglobulin G N-glycans are accessible and dynamic. Nat Chem Biol. 2011;7:147–153. doi: 10.1038/nchembio.511. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Yamaguchi Y, Nishimura M, Nagano M, Yagi H, Sasakawa H, Uchida K, Shitara K, Kato K. Glycoform-dependent conformational alteration of the Fc region of human immunoglobulin G1 as revealed by NMR spectroscopy. Biochim Biophys Acta. 2006;1760:693–700. doi: 10.1016/j.bbagen.2005.10.002. [DOI] [PubMed] [Google Scholar]
- 13.Kaneko Y, Nimmerjahn F, Ravetch JV. Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation. Science. 2006;313:670–673. doi: 10.1126/science.1129594. [DOI] [PubMed] [Google Scholar]
- 14.Anthony RM, Nimmerjahn F, Ashline DJ, Reinhold VN, Paulson JC, Ravetch JV. Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc. Science. 2008;320:373–376. doi: 10.1126/science.1154315. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Durocher Y, Butler M. Expression systems for therapeutic glycoprotein production. Curr Opin Biotechnol. 2009;20:700–707. doi: 10.1016/j.copbio.2009.10.008. [DOI] [PubMed] [Google Scholar]
- 16.Hus JC, Marion D, Blackledge M. De novo determination of protein structure by NMR using orientational and long-range order restraints. J Mol Biol. 2000;298:927–936. doi: 10.1006/jmbi.2000.3714. [DOI] [PubMed] [Google Scholar]
- 17.Koehler J, Meiler J. Expanding the utility of NMR restraints with paramagnetic compounds: background and practical aspects. Prog Nucl Magn Reson Spectrosc. 2011;59:360–389. doi: 10.1016/j.pnmrs.2011.05.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Wüthrich K. NMR of proteins and nucleic acids. New York: Wiley; 1986. p. xv. 292. [Google Scholar]
- 19.Xie J, Liu W, Schultz PG. A genetically encoded bidentate, metal-binding amino acid. Angew Chem Int Ed Engl. 2007;46:9239–9242. doi: 10.1002/anie.200703397. [DOI] [PubMed] [Google Scholar]
- 20.Nitz M, Franz KJ, Maglathlin RL, Imperiali B. A powerful combinatorial screen to identify high-affinity terbium(III)-binding peptides. Chembiochem. 2003;4:272–276. doi: 10.1002/cbic.200390047. [DOI] [PubMed] [Google Scholar]
- 21.Zhuang T, Lee HS, Imperiali B, Prestegard JH. Structure determination of a Galectin-3-carbohydrate complex using paramagnetism-based NMR constraints. Protein Sci. 2008;17:1220–1231. doi: 10.1110/ps.034561.108. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Su XC, Huber T, Dixon NE, Otting G. Site-specific labelling of proteins with a rigid lanthanide-binding tag. Chembiochem. 2006;7:1599–1604. doi: 10.1002/cbic.200600142. [DOI] [PubMed] [Google Scholar]
- 23.Häussinger D, Huang JR, Grzesiek S. DOTA-M8: an extremely rigid, high-affinity lanthanide chelating tag for PCS NMR spectroscopy. J Am Chem Soc. 2009;131:14761–14767. doi: 10.1021/ja903233w. [DOI] [PubMed] [Google Scholar]
- 24.Saio T, Ogura K, Yokochi M, Kobashigawa Y, Inagaki F. Two-point anchoring of a lanthanide-binding peptide to a target protein enhances the paramagnetic anisotropic effect. J Biomol NMR. 2009;44:157–166. doi: 10.1007/s10858-009-9325-z. [DOI] [PubMed] [Google Scholar]
- 25.Barthelmes K, Reynolds AM, Peisach E, Jonker HR, DeNunzio NJ, Allen KN, Imperiali B, Schwalbe H. Engineering encodable lanthanide-binding tags into loop regions of proteins. J Am Chem Soc. 2010;133:808–819. doi: 10.1021/ja104983t. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Nilsson B, Moks T, Jansson B, Abrahmsen L, Elmblad A, Holmgren E, Henrichson C, Jones TA, Uhlen M. A synthetic IgG-binding domain based on staphylococcal protein A. Protein Eng. 1987;1:107–113. doi: 10.1093/protein/1.2.107. [DOI] [PubMed] [Google Scholar]
- 27.Burton DR. Immunoglobulin G: functional sites. Mol Immunol. 1985;22:161–206. doi: 10.1016/0161-5890(85)90151-8. [DOI] [PubMed] [Google Scholar]
- 28.Tashiro M, Tejero R, Zimmerman DE, Celda B, Nilsson B, Montelione GT. High-resolution solution NMR structure of the Z domain of staphylococcal protein A. J Mol Biol. 1997;272:573–590. doi: 10.1006/jmbi.1997.1265. [DOI] [PubMed] [Google Scholar]
- 29.Zheng D, Aramini JM, Montelione GT. Validation of helical tilt angles in the solution NMR structure of the Z domain of Staphylococcal protein A by combined analysis of residual dipolar coupling and NOE data. Protein Sci. 2004;13:549–554. doi: 10.1110/ps.03351704. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Lendel C, Dincbas-Renqvist V, Flores A, Wahlberg E, Dogan J, Nygren PA, Härd T. Biophysical characterization of Z(SPA-1)—a phage-display selected binder to protein A. Protein Sci. 2004;13:2078–2088. doi: 10.1110/ps.04728604. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Bhattacharya A, Tejero R, Montelione GT. Evaluating protein structures determined by structural genomics consortia. Proteins. 2007;66:778–795. doi: 10.1002/prot.21165. [DOI] [PubMed] [Google Scholar]
- 32.Eisenberg D, Luthy R, Bowie JU. VERIFY3D: assessment of protein models with three-dimensional profiles. Methods Enzymol. 1997;277:396–404. doi: 10.1016/s0076-6879(97)77022-8. [DOI] [PubMed] [Google Scholar]
- 33.Sippl MJ. Recognition of errors in 3-dimensional structures of proteins. Proteins. 1993;17:355–362. doi: 10.1002/prot.340170404. [DOI] [PubMed] [Google Scholar]
- 34.Laskowski RA, Macarthur MW, Moss DS, Thornton JM. Procheck—a program to check the stereochemical quality of protein structures. J Appl Crystallogr. 1993;26:283–291. [Google Scholar]
- 35.Davis IW, Leaver-Fay A, Chen VB, Block JN, Kapral GJ, Wang X, Murray LW, Arendall WB, Snoeyink J, Richardson JS, et al. MolProbity: all-atom contacts and structure validation for proteins and nucleic acids. Nucleic Acids Res. 2007;35:W375–W383. doi: 10.1093/nar/gkm216. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Nitz M, Sherawat M, Franz KJ, Peisach E, Allen KN, Imperiali B. Structural origin of the high affinity of a chemically evolved lanthanide-binding peptide. Angew Chem Int Ed Engl. 2004;43:3682–3685. doi: 10.1002/anie.200460028. [DOI] [PubMed] [Google Scholar]
- 37.Cornilescu G, Marquardt JL, Ottiger M, Bax A. Validation of protein structure from anisotropic carbonyl chemical shifts in a dilute liquid crystalline phase. J Am Chem Soc. 1998;120:6836–6837. [Google Scholar]
- 38.Schwieters CD, Kuszewski JJ, Tjandra N, Clore GM. The Xplor-NIH NMR molecular structure determination package. J Magn Reson. 2003;160:65–73. doi: 10.1016/s1090-7807(02)00014-9. [DOI] [PubMed] [Google Scholar]
- 39.Pintacuda G, Kaikkonen A, Otting G. Modulation of the distance dependence of paramagnetic relaxation enhancements by CSA x DSA cross-correlation. J Magn Reson. 2004;171:233–243. doi: 10.1016/j.jmr.2004.08.019. [DOI] [PubMed] [Google Scholar]
- 40.Idusogie EE, Presta LG, Gazzano-Santoro H, Totpal K, Wong PY, Ultsch M, Meng YG, Mulkerrin MG. Mapping of the C1q binding site on rituxan, a chimeric antibody with a human IgG1 Fc. J Immunol. 2000;164:4178–4184. doi: 10.4049/jimmunol.164.8.4178. [DOI] [PubMed] [Google Scholar]
- 41.Chen YY, Luo SY, Hung SC, Chan SI, Tzou DL. 13C solid-state NMR chemical shift anisotropy analysis of the anomeric carbon in carbohydrates. Carbohydr Res. 2005;340:723–729. doi: 10.1016/j.carres.2005.01.018. [DOI] [PubMed] [Google Scholar]
- 42.Tugarinov V, Scheurer C, Bruschweiler R, Kay LE. Estimates of methyl 13C and 1H CSA values (Deltasigma) in proteins from cross-correlated spin relaxation. J Biomol NMR. 2004;30:397–406. doi: 10.1007/s10858-004-4349-x. [DOI] [PubMed] [Google Scholar]
- 43.Loth K, Pelupessy P, Bodenhausen G. Chemical shift anisotropy tensors of carbonyl, nitrogen, and amide proton nuclei in proteins through cross-correlated relaxation in NMR spectroscopy. J Am Chem Soc. 2005;127:6062–6068. doi: 10.1021/ja042863o. [DOI] [PubMed] [Google Scholar]
- 44.Barb AW, Borgert AJ, Liu M, Barany G, Live D. Intramolecular glycan-protein interactions in glycoproteins. Methods Enzymol. 2010;477:365–388. doi: 10.1016/S0076-6879(10)78018-6. [DOI] [PubMed] [Google Scholar]
- 45.Goulle JP, Cattaneo A, Saussereau E, Mahieu L, Guerbet M, Lacroix C. MRI gadolinium-based contrast agents. Radiologists beware! Ann Pharm Fr. 2009;67:335–339. doi: 10.1016/j.pharma.2009.06.002. [DOI] [PubMed] [Google Scholar]
- 46.Lofblom J, Feldwisch J, Tolmachev V, Carlsson J, Stahl S, Frejd FY. Affibody molecules: engineered proteins for therapeutic, diagnostic and biotechnological applications. FEBS Lett. 2010;584:2670–2680. doi: 10.1016/j.febslet.2010.04.014. [DOI] [PubMed] [Google Scholar]
- 47.Nilsson FY, Tolmachev V. Affibody molecules: new protein domains for molecular imaging and targeted tumor therapy. Curr Opin Drug Discov Devel. 2007;10:167–175. [PubMed] [Google Scholar]
- 48.Denk W, Strickler JH, Webb WW. Two-photon laser scanning fluorescence microscopy. Science. 1990;248:73–76. doi: 10.1126/science.2321027. [DOI] [PubMed] [Google Scholar]
- 49.Carr HY, Purcell EM. Effects of diffusion on free precession in nuclear magnetic resonance experiments. Phys Rev. 1954;94:630–638. [Google Scholar]
- 50.Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J, Bax A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J Biomol NMR. 1995;6:277–293. doi: 10.1007/BF00197809. [DOI] [PubMed] [Google Scholar]
- 51.Johnson BA. Using NMRView to visualize and analyze the NMR spectra of macromolecules. Methods Mol Biol. 2004;278:313–352. doi: 10.1385/1-59259-809-9:313. [DOI] [PubMed] [Google Scholar]
- 52.Rückert M, Otting G. Alignment of biological macromolecules in novel nonionic liquid crystalline media for NMR experiments. J Am Chem Soc. 2000;122:7793–7797. [Google Scholar]
- 53.Tjandra N, Grzesiek S, Bax A. Magnetic field dependence of nitrogen-proton J splittings in N-15-enriched human ubiquitin resulting from relaxation interference and residual dipolar coupling. J Am Chem Soc. 1996;118:6264–6272. [Google Scholar]
- 54.Liu YZ, Prestegard JH. Measurement of one and two bond N-C couplings in large proteins by TROSY-based J-modulation experiments. J Magn Reson. 2009;200:109–118. doi: 10.1016/j.jmr.2009.06.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Barjat H, Chilvers PB, Fetler BK, Horne TJ, Morris GA. A practical method for automated shimming with normal spectrometer hardware. J Magn Reson. 1997;125:197–201. doi: 10.1006/jmre.1996.1094. [DOI] [PubMed] [Google Scholar]
- 56.Cornilescu G, Delaglio F, Bax A. Protein backbone angle restraints from searching a database for chemical shift and sequence homology. J Biomol NMR. 1999;13:289–302. doi: 10.1023/a:1008392405740. [DOI] [PubMed] [Google Scholar]
- 57.Zweckstetter M, Bax A. Prediction of sterically induced alignment in a dilute liquid crystalline phase: aid to protein structure determination by NMR. J Am Chem Soc. 2000;122:3791–3792. [Google Scholar]
- 58.Schmitz C, Stanton-Cook MJ, Su XC, Otting G, Huber T. Numbat: an interactive software tool for fitting Deltachi-tensors to molecular coordinates using pseudocontact shifts. J Biomol NMR. 2008;41:179–189. doi: 10.1007/s10858-008-9249-z. [DOI] [PubMed] [Google Scholar]
- 59.Banci L, Bertini I, Cavallaro G, Giachetti A, Luchinat C, Parigi G. Paramagnetism-based restraints for Xplor-NIH. J Biomol NMR. 2004;28:249–261. doi: 10.1023/B:JNMR.0000013703.30623.f7. [DOI] [PubMed] [Google Scholar]
- 60.Abramoff MD, Magalhaes PJ, Ram SJ. Image processing with imageJ. Biophotonics Int. 2004;11:36–42. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
